Track the OrbusNeich Medical Group Holdings Ltd. stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €3.3bn. The latest transaction was reported on 18 June 2026 (Purchase). Among the most active insiders: Chen Wing Shing. The full history is openly available.
Analysts rate OrbusNeich Medical Group Holdings Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: HK$5.61.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
OrbusNeich Medical Group Holdings Ltd. es una empresa especializada en el desarrollo y la fabricación de dispositivos médicos para el tratamiento de enfermedades cardiovasculares. Se centra en la innovación y la mejora de los resultados clínicos para los pacientes.